Profile picture

Mr Wei Liu

Beijing Jishuitan Hospital, Beijing (China)
Membership: FESC Member
Follow
Logo ESC

Contributor content

Five-years outcomes of biodegradable polymer drug-eluting stents versus the second-generation durable polymer drug-eluting stents: a meta-analysis of randomized controlled trials
Presentation
Five-years outcomes of biodegradable polymer drug-eluting stents versus the second-generation durable polymer drug-eluting stents: a meta-analysis of randomized controlled trials
The clinical experience of J valve transapical transcatheter aortic valve replacement system in high-risk patients with severe pure aortic regurgitation
Presentation
The clinical experience of J valve transapical transcatheter aortic valve replacement system in high-risk patients with severe pure aortic regurgitation
Nomograms to predict occurrence of major bleeding in patients undergoing off-pump coronary artery bypass grafting
Presentation
Nomograms to predict occurrence of major bleeding in patients undergoing off-pump coronary artery bypass grafting
Impact of major bleeding on the risk of postoperative myocardial infarction in patients undergoing off-pump coronary artery bypass grafting
Presentation
Impact of major bleeding on the risk of postoperative myocardial infarction in patients undergoing off-pump coronary artery bypass grafting
The effect of CYP2C19 gene polymorphism on clinical outcomes in patients with CAD receiving antiplatelet therapy.
Presentation
The effect of CYP2C19 gene polymorphism on clinical outcomes in patients with CAD receiving antiplatelet therapy.
The effect of CYP2C19 gene polymorphism and clopidogrel dose on clinical outcomes in Asian populations with CAD receiving antiplatelet therapy.
Presentation
The effect of CYP2C19 gene polymorphism and clopidogrel dose on clinical outcomes in Asian populations with CAD receiving antiplatelet therapy.
Bleeding and risk of acute kidney injury post off pump coronary bypass in patients with acute coronary syndrome
Presentation
Bleeding and risk of acute kidney injury post off pump coronary bypass in patients with acute coronary syndrome
Can off-pump coronary artery bypass graft surgery be performed 3 days after clopidogrel discontinuation without increasing the bleeding risk in acute coronary syndrome patients?
Presentation
Can off-pump coronary artery bypass graft surgery be performed 3 days after clopidogrel discontinuation without increasing the bleeding risk in acute coronary syndrome patients?

ESC 365 is supported by